康沣生物-B拟发行746万股认购股份 净筹约3973万港元

Core Viewpoint - 康沣生物-B has entered into a subscription agreement to issue a total of 7.46 million H-shares at a price of HKD 5.36 per share, representing a discount of approximately 17.79% from the closing price on the day of the announcement [2] Group 1 - The net proceeds from the subscription are approximately HKD 39.73 million [2] - 80% of the proceeds will be allocated for the research, production, commercialization, and potential overseas expansion of minimally invasive products related to vascular, respiratory, and oncology interventions [2] - The remaining 20% will be used for the company's general working capital [2]